Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Download
Faster access than browser!
 

Memantine and Receptor antagonist

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Memantine and Receptor antagonist

Memantine vs. Receptor antagonist

Memantine is used to treat moderate to severe Alzheimer's disease. It acts on the glutamatergic system by blocking NMDA receptors. It was first synthesized by Eli Lilly and Company in 1968 as a potential agent to treat diabetes; the NMDA activity was discovered in the 1980s. A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.

Similarities between Memantine and Receptor antagonist

Memantine and Receptor antagonist have 3 things in common (in Unionpedia): Agonist, Alzheimer's disease, NMDA receptor.

Agonist

An agonist is a chemical that binds to a receptor and activates the receptor to produce a biological response.

Agonist and Memantine · Agonist and Receptor antagonist · See more »

Alzheimer's disease

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time.

Alzheimer's disease and Memantine · Alzheimer's disease and Receptor antagonist · See more »

NMDA receptor

The N-methyl-D-aspartate receptor (also known as the NMDA receptor or NMDAR), is a glutamate receptor and ion channel protein found in nerve cells.

Memantine and NMDA receptor · NMDA receptor and Receptor antagonist · See more »

The list above answers the following questions

Memantine and Receptor antagonist Comparison

Memantine has 58 relations, while Receptor antagonist has 60. As they have in common 3, the Jaccard index is 2.54% = 3 / (58 + 60).

References

This article shows the relationship between Memantine and Receptor antagonist. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »